```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 10175 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                               H. R. 10175

   To authorize United States participation in the Davos Alzheimer's 
                             Collaborative.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           November 20, 2024

  Mr. Bera (for himself, Mr. Fitzpatrick, and Mrs. Kim of California) 
 introduced the following bill; which was referred to the Committee on 
                            Foreign Affairs

_______________________________________________________________________

                                 A BILL

 
   To authorize United States participation in the Davos Alzheimer's 
                             Collaborative.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Global Alzheimer's Initiative Now 
Act''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) Alzheimer's disease and dementia currently afflicts 
        nearly 60 million people across the globe, a number that is 
        projected to jump to more than 150 million by 2050.
            (2) There are now more global cases of Alzheimer's disease 
        and dementia than cancer and HIV combined, with 39 million 
        diagnosed cases of HIV/AIDS and 20 million cases of cancer in 
        2022.
            (3) The pace of populations aging will challenge countries' 
        sovereign funds and health and social safety systems.
            (4) By 2050, the world's population of people aged 60 years 
        and older will double to 1.6 billion and reach a proportion of 
        22 percent of the world's population. While the number of 
        persons aged 80 or older is expected to triple by 2050.
            (5) The old-age dependency ratio, expressing the relative 
        size of the older population compared with the working-age 
        population, is projected to more than double by 2075 in the 
        majority of the world. Rising dependency ratios will result in 
        increasing pressures on old-age support systems, with fewer 
        people of working age for each older person.
            (6) The prevalence of Alzheimer's disease and dementia is 
        growing most rapidly in low- and middle-income countries, which 
        comprise more than 70 percent of the world's Alzheimer's 
        disease and dementia cases.
            (7) Every year, Alzheimer's disease and dementia costs the 
        global economy more than $1.3 trillion and this is doubling 
        every decade.
            (8) By 2050, the number of Americans living with 
        Alzheimer's disease and dementia is expected to reach 12.7 
        million, bringing the total cost to nearly $1 trillion each 
        year.
            (9) Women are disproportionately affected by Alzheimer's 
        disease and dementia, both directly and indirectly. Women 
        experience higher disability-adjusted life years and mortality 
        due to Alzheimer's disease and dementia, but also provide 70 
        percent of care hours for people living with Alzheimer's 
        disease and dementia.
            (10) The Davos Alzheimer's Collaborative (DAC) is a public-
        private-patient venture, launched in 2021, that is transforming 
        Alzheimer's disease and dementia research, prevention, and care 
        in low-income, middle-income, and high-income settings 
        globally.
            (11) DAC seeks to raise and deploy over $700 million over 6 
        years to accelerate innovation in drug development and 
        transform the way healthcare systems prevent, diagnose, and 
        treat Alzheimer's disease and dementia for all people in all 
        places.
            (12) In 2023, DAC supported 19 healthcare systems in 12 
        countries, including the United States.
            (13) The United States Government is the largest funder of 
        global health programs, with approximately $12 billion in 
        annual funding for programs that cover the full range of global 
        health challenges.
            (14) USAID and the Department of State are lead funders of 
        multilateral health initiatives, such as Gavi, the Vaccine 
        Alliance, the Global Fund to Fight AIDS, TB and Malaria, the 
        Coalition for Epidemic Preparedness Innovations, and the 
        International AIDS Vaccine Initiative.

SEC. 3. STATEMENT OF POLICY.

    It shall be the policy of the United States--
            (1) to lead global cooperative efforts to combat 
        Alzheimer's disease and dementia, including in countries with 
        low-income economies and countries with middle-income economies 
        (as such terms are defined by the World Bank) that represent 
        the majority of future cases; and
            (2) to lead multilateral health initiatives, including the 
        Davos Alzheimer's Collaborative--
                    (A) to develop diagnostics and treatments for 
                diverse populations in the United States and across the 
                globe;
                    (B) to promote international development 
                cooperation; and
                    (C) to provide substantial leverage and burden 
                sharing for United States investments.

SEC. 4. AUTHORIZATION FOR UNITED STATES PARTICIPATION IN THE DAVOS 
              ALZHEIMER'S COLLABORATIVE.

    (a) In General.--The United States is hereby authorized to 
participate in, and contribute to, the Davos Alzheimer's Collaborative 
(DAC) in order to advance international efforts to prevent, diagnose, 
and treat Alzheimer's disease and dementia.
    (b) Designee.--
            (1) In general.--The President is authorized to designate 
        an employee of the relevant Federal department or agency 
        providing the majority of United States contributions to DAC to 
        serve on the Advisory Council of DAC and, if nominated, on the 
        Board of Directors of DAC, as a representative of the United 
        States.
            (2) Qualifications.--The individual to be designated 
        pursuant to paragraph (1) should demonstrate knowledge and 
        experience in the fields of development and public health.
            (3) Cooperation.--In carrying out this section, the 
        individual designated pursuant to paragraph (1) shall 
        coordinate with the USAID Administrator, the Secretary of 
        State, and the Secretary of Health and Human Services to 
        promote alignment, as appropriate, between DAC and United 
        States global health and Alzheimer's disease and dementia 
        research and development programs.
    (c) United States Contributions.--
            (1) In general.--Amounts authorized to be appropriated and 
        made available to carry out chapters 1 and 10 of part I and 
        chapter 4 of part II of the Foreign Assistance Act of 1961 (22 
        U.S.C. 2151 et seq.) are authorized to be made available for 
        United States contributions to DAC.
            (2) Matching requirement.--Amounts made available under 
        paragraph (1) may be obligated and expended only to the extent 
        that DAC secures funding from sources other than the United 
        States. At any time during fiscal years 2025 through 2029, no 
        United States contribution to DAC may cause the total amount of 
        United States Government contributions to DAC to exceed 33 
        percent of the total amount of funds contributed to the DAC 
        from all sources.
    (d) Report.--Not later than 180 days after the date of the 
enactment of this Act, and on an annual basis thereafter, the President 
shall submit to the appropriate congressional committees a report that 
includes the following:
            (1) A description of any planned financial contributions 
        from the United States Government to DAC.
            (2) The manner and extent to which the United States will 
        participate in the governance of DAC.
            (3) A summary of private and governmental contributions to 
        DAC.
            (4) A description of how participation in DAC supports 
        relevant United States Government strategies and programs to 
        combat Alzheimer's disease and dementia and to promote global 
        health.
    (e) Definition.--In subsection (d), the term ``appropriate 
congressional committees'' means--
            (1) the Committee on Foreign Affairs and Committee on 
        Appropriations of the House of Representatives; and
            (2) the Committee on Foreign Relations and the Committee on 
        Appropriations of the Senate.
                                 <all>
```